http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100469213-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
filingDate 2002-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100469213-B1
titleOfInvention Calix[4]arene-nucleoside and calix[4]arene-oligonucleotide hybrids and method for the preparation thereof
abstract BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel calixarene-nucleoside hybrids (calix [4] arene-nucleoside hybrids) and calixsarene-oligonucleotide hybrids (Calix [4] arene-oligonucleotide hybrids) and methods for preparing the same. The present invention relates to a Kalixaren-Nucleoside hybrid comprising a Kalixaren residue and a Kalixaren-Oligonucleotide hybrid capable of acting as a DNA hairpin structure mimics using it as a building block. The calixarene-nucleoside and calixaren-oligonucleotide hybrids of the present invention will be able to effectively recognize DNA or RNA through the formation of a triplex by combining a cavity with a calixarene and a bioactive substance.
priorityDate 2002-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23255465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421128521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447706689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2805912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425965249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11740710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421128514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448840407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131737235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416201511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416154797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449982031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733207

Total number of triples: 42.